Penumbra, Inc.
PEN
Jodie situation report
Penumbra, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 26 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.
- PEN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if PEN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind PEN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BSXBoston Scientific CorporationpartnerMay 6, 2026 ▾
“The increase was primarily due to a $17.2 million increase in personnel-related expenses driven by an increase in headcount and related expenses to support our growth, a $9.4 million increase in acquisition-related expenses primarily attributable to professio…”
BSXBoston Scientific CorporationcompetitorFeb 25, 2026 ▾
“Our most notable competitors are Boston Scientific, Medtronic, Stryker (now including Inari Medical), Terumo and several private companies.”
Depended on by
OSRHOSR Health, Inc.distributorMar 31, 2026 ▾
“32 Since 2015, RMC has also distributed neuro-intervention medical device equipment manufactured by Penumbra Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
PEN is currently a Follower in the organic co-movement group High-Beta Risk-On. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.